John Jed Kennedy - Mar 3, 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Signature
Sarah M. Oliker for John (Jed) Kennedy by Power of Attorney
Stock symbol
CNMD
Transactions as of
Mar 3, 2022
Transactions value $
-$585,368
Form type
4
Date filed
3/7/2022, 04:08 PM
Previous filing
Mar 3, 2022
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $305K +5.09K +51.67% $59.96 14.9K Mar 3, 2022 Direct
transaction CNMD Common Stock Sale -$735K -5.09K -34.07% $144.25 9.86K Mar 3, 2022 Direct F1
transaction CNMD Common Stock Options Exercise $141K +1.79K +18.16% $78.76 11.6K Mar 3, 2022 Direct
transaction CNMD Common Stock Sale -$258K -1.79K -15.37% $144.32 9.86K Mar 3, 2022 Direct F2
transaction CNMD Common Stock Options Exercise $81.3K +832 +8.44% $97.69 10.7K Mar 3, 2022 Direct
transaction CNMD Common Stock Sale -$120K -832 -7.79% $144.33 9.86K Mar 3, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5.09K -48.53% $0.00 5.4K Mar 3, 2022 Common Stock 5.09K $59.96 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1.79K -32.02% $0.00 3.8K Mar 3, 2022 Common Stock 1.79K $78.76 Direct F5
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -832 -10.95% $0.00 6.77K Mar 3, 2022 Common Stock 832 $97.69 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.25 to $144.36. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.50. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.40. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period